...

Brady Smith

On Top of 2023

Now that 2022 is officially over and the holidays are in our rear-view mirrors, there is some actual movement that makes us think 2023 may be the year we see some of them finally settle, and others really take off. Bad News First – Zantac First, the bad news – the Zantac litigation suffered some

On Top of 2023 Read More »

Drug safety Risks

By Martha Rosenberg Stay Hidden As HYPOCHONDRIA Is Created By Marketing If you’re like most people, you never heard of the prescription drug Humira until 2013. That’s when Abbott Laboratories spun off AbbVie, to aggressively market the rheumatoid arthritis (RA) drug which went on to become the top selling drug by 2019. Humira marketing is

Drug safety Risks Read More »

Best Case Leads

Seraphinite AcceleratorOptimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.